NCT03860584
- Conditions
- Body Weight, Glucose Metabolism Disorders, Hyperinsulinism, +13 more
- Locations
-
- The Ohio State University Columbus, Ohio, United States
Clinical trial condition
Obesity
Explore clinical trials studying Obesity. Study availability and eligibility vary by location and protocol.
9,119 public trials
1,141 recruiting studies
Obesity trial results
Completed
Effect of Akkermansia Muciniphila Akk11 on Metabolic and Gut Health in Overweight and Obese Subjects
NCT06653101
- Conditions
- Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +6 more
- Locations
-
- Fei Xu Zhengzhou, None Selected, China
NCT06542536
- Conditions
- Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +5 more
- Locations
-
- Altasciences Clinical LA, Inc. Cypress, California, United States
NCT05064735
- Conditions
- Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +5 more
- Locations
-
- Baptist Health System Montgomery, Alabama, United States
- Ortho Arizona Phoenix, Arizona, United States
- Anaheim Clinical Trials, LLC Anaheim, California, United States
- Stuart L. Silverman MD - A Medical Corporation Beverly Hills, California, United States
NCT00264589
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
- Locations
-
- Service d'Explorations et de Médecine Vasculaire University Hospital Center Nîmes, Nimes, France
NCT07230704
- Conditions
- Bariatric Surgery Candidate, Body Weight, Inflammation, +8 more
- Locations
-
- Adana City Training and Research Hospital Adana, Turkey (Türkiye)
Completed
Healthy Eating and Active Living Taught at Home (HEALTH) Dissemination & Implementation (D&I)
NCT03758638
- Conditions
- Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +5 more
- Locations
-
- Washington University in St. Louis St Louis, Missouri, United States
Completed
A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
NCT06804603
- Conditions
- Body Weight, Nausea, Nutrition Disorders, +8 more
- Locations
-
- Vanda Investigational Site Los Angeles, California, United States
- Vanda Investigational Site Rochester, Minnesota, United States
- Vanda Investigational Site New York, United States
Completed
Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesity
NCT06771115
- Conditions
- Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +5 more
- Locations
-
- 840005 Birmingham, Alabama, United States
- 840003 Lake Forest, California, United States
- 840011 Long Beach, California, United States
- 840001 Largo, Florida, United States
Completed
The SCULPT-Job Cohort Study
NCT06965075
- Conditions
- Behavior, Behavioral Symptoms, Body Weight, +17 more
- Locations
-
- YMCA-Bayview San Francisco, California, United States